Skip to main content

Peer Review reports

From: The impact of inclusion, dose and duration of pyrazinamide (PZA) on efficacy and safety outcomes in tuberculosis: systematic review and meta-analysis protocol

Original Submission
24 Aug 2019 Submitted Original manuscript
4 Nov 2019 Author responded Author comments - James Millard
Resubmission - Version 2
4 Nov 2019 Submitted Manuscript version 2
12 Nov 2019 Editorially accepted
17 Dec 2019 Article published 10.1186/s13643-019-1231-1

You can find further information about peer review here.

Back to article page